Kelly Wilson

Direttore operativo presso BIOSTAX CORP.

Patrimonio netto: 671 165 $ in data 31/05/2024

53 anni

Health Technology

Consumer Services

Posizioni attive di Kelly Wilson

Società	Posizione	Inizio	Fine
BIOSTAX CORP.	Direttore operativo	01/08/2022	-
Forte Animal Health, Inc.	Direttore/Membro del Consiglio	01/12/2020	-

Società	Posizione	Inizio	Fine
BIOSTAX CORP.	Amministratore Delegato	03/11/2022	25/07/2023
	Direttore operativo	01/08/2022	25/07/2023
	Contatto Relazioni con gli Investitori	03/11/2022	25/07/2023
	Presidente	03/11/2022	12/04/2023
BIOSTAX CORP.	Direttore Tecnico/Scientifico/R&S	01/01/2013	01/04/2020
BIOSTAX CORP.	Ufficiale delle Risorse Umane	01/01/2015	01/04/2020
Cytocom, Inc. /Old/ Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL.	Direttore Tecnico/Scientifico/R&S	01/09/2016	01/04/2020

University of Central Florida

Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
BIOSTAX CORP.	Health Technology

Aziende private	2
Cytocom, Inc. /Old/ Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL.	Health Technology
Forte Animal Health, Inc.